MSB 0.47% $1.07 mesoblast limited

I cannot believe whats going on on this thread just a few clips...

  1. 5,344 Posts.
    lightbulb Created with Sketch. 957
    I cannot  believe whats going  on  on  this  thread just a few  clips (IT IS NOT SO MUCH THE JAGGING OF THE MULTI-BAGGERS THAT MATTERS, AS IT IS TO AVOID PERMANENT CAPITAL LOSSES.)(One of my biggest positions today is a company I followed very closely for close to 3 years(!) before the event finally occurred that made me believe that my downside was adequately protected in terms of the probability of avoiding permanent capital loss.)(The question of how Teva views its relationship with MSB is a question best asked of Teva itself.)............Whilst  I do  read  your  posts and you  have  some points , you fail with honours with the very  simple skills in investing long term and no  doubt  thats  your  aim  ..You contine to worry  about permanent loss of  your  capitol, any investor or trader  knows you  can limit  that with stop losses which  cost nothing so  maybe you  lose  5%-10% of  your initial outlay also  you  can set buys etc.etc. so there  is  no need  to  wait  for  years  to  decide what  u  want to  invest  in.. While  on  the stops and set buys there  is another choice for shorters .I often read short buyers  are going  to  get  burnt , not nowdays because some are algro. trading groups and have stop rises in place (sell) only  to  watch the rise then start  the short  cycle over  again  ..There  other large holders and im talking  sub. who  dont  short  sell who  churn MSB like  you  would  not  believe, there are a handful  on  this  thread who  can  see  this  daily ...Anybody can  do  all  the  research in  the world on  MSB but  they  never  do  the  most  basic ,they  look and look at a forest and dont see  the  trees  ........
    Rank Investor No. of shares held % of total shares
    1 HSBC Custody Nominees (Australia) Limited 68,073,766 21.45%
    2 Professor Silviu Itescu 67,751,838 21.35%
    3 Teva. 55,785,806 17.58%
    4 National Nominees Limited 19,521,951 6.15%
    5 J P Morgan Nominees Australia Limited 16,432,452 5.18%
    6 Thorney Holdings Pty Ltd 14,332,168 4.52%
    7 JP Morgan Nominees Australia Limited 7,187,178 2.26%
    8 Dalit Pty Ltd 4,468,839 1.41%
    9 Mesoblast Australia Pty Ltd* 4,120,000 1.30%
    10 Citicorp Nominees Pty Limited 3,798,530 1.20%
    11 UBS Nominees Pty Limited 3,377,832 1.06%
    12 Trustees of the Columbia University in the City of New York 2,330,096 0.73%
    13 Adelaide Health Services Inc 1,953,000 0.62%
    14 JGM Investment Group Pty Ltd 1,881,200 0.59%
    15 Avister Pty Ltd 1,578,354 0.50%
    16 BNP Paribas Noms Pty Ltd 1,365,444 0.43%
    17 CS Fourth Nominees Pty Ltd 1,231,433 0.39%
    18 Tigcorp Nominees Pty Ltd 1,060,000 0.33%
    19 Michael Spooner 976,606 0.31%
    20 J G M Investment Group Pty Ltd 929,742 0.29%
    278,156,235 87.65%Read  that but  thats  not all Teva may  have 55.7 mill shares but they a lot  more  stake  in  MSB. also Capital have purchsed 3.3mill in 2014 they  are  not  on  the  list  .....substantial  holders and top 20 own 278.m out of 321.6 mill shares issued which leaves around only 43 m shares with retailers which is declining rapidly.. My main issue  here  is  of  all  the  substantial holders and yep  over  ten  years I  can  recall  only  one seller  and  he  still  holds  over  20%, keep  in  mind the  latest sub. buyer  got  in  at  $6.30 in 2014 and  the others have ridden  it  to  10 $  and  sold nothing ..to  me  thats  easy  research without all  the head banging ...interesting to  google a few  of  the  top  20  ....Cheers Vin
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
0.005(0.47%)
Mkt cap ! $1.216B
Open High Low Value Volume
$1.08 $1.10 $1.06 $3.371M 3.135M

Buyers (Bids)

No. Vol. Price($)
8 45345 $1.06
 

Sellers (Offers)

Price($) Vol. No.
$1.07 3875 2
View Market Depth
Last trade - 16.10pm 03/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.